Literature DB >> 19155503

Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes.

Jason D Walker1, Cheryl L Maier, Jordan S Pober.   

Abstract

Human CMV infection is controlled by T cell-mediated immunity and in immunosuppressed transplant patients it is associated with acute allograft rejection as well as chronic allograft vasculopathy. CMV infects endothelial cells (EC) and it is thought that CMV-specific host immune responses to infected allograft EC contribute to rejection. In vitro, CD4(+) T cells from CMV-positive donors (but not CMV-negative donors) are readily activated by CMV-infected allogeneic EC, although it is unclear how allogeneic CMV-infected EC activate self-class II MHC-restricted memory CD4(+) T cells. In this study, we confirm that purified CD4(+) T cells from CMV(+) donors are activated by allogeneic CMV-infected EC, but find that the response is dependent upon copurified APC expressing class II MHC that are autologous to the T cells. The transfer of CMV Ags from infected EC to APC can be mediated by EC-derived exosome-like particles. These results provide a mechanism by which CMV can exacerbate allograft rejection and suggest a novel function of EC-derived exosomes that could contribute in a more general manner to immune surveillance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19155503      PMCID: PMC2630120          DOI: 10.4049/jimmunol.182.3.1548

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

1.  Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells.

Authors:  Cynthia A Bolovan-Fritts; Rodney N Trout; Stephen A Spector
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Exosomal-like vesicles are present in human blood plasma.

Authors:  Marie-Pierre Caby; Danielle Lankar; Claude Vincendeau-Scherrer; Graça Raposo; Christian Bonnerot
Journal:  Int Immunol       Date:  2005-05-20       Impact factor: 4.823

3.  Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses.

Authors:  Elodie Segura; Sebastian Amigorena; Clotilde Théry
Journal:  Blood Cells Mol Dis       Date:  2005 Sep-Oct       Impact factor: 3.039

4.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.

Authors:  V Combes; A C Simon; G E Grau; D Arnoux; L Camoin; F Sabatier; M Mutin; M Sanmarco; J Sampol; F Dignat-George
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

5.  Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

Authors:  H A Valantine; S Z Gao; S G Menon; D G Renlund; S A Hunt; P Oyer; E B Stinson; B W Brown; T C Merigan; J S Schroeder
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

6.  Human cytomegalovirus. I. Purification and characterization of viral DNA.

Authors:  E S Huang; S T Chen; J S Pagano
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

7.  Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells.

Authors:  R Tomazin; J Boname; N R Hegde; D M Lewinsohn; Y Altschuler; T R Jones; P Cresswell; J A Nelson; S R Riddell; D C Johnson
Journal:  Nat Med       Date:  1999-09       Impact factor: 53.440

8.  The cathepsin B death pathway contributes to TNF plus IFN-gamma-mediated human endothelial injury.

Authors:  Jie Hui Li; Jordan S Pober
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

9.  Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells.

Authors:  Adrian E Morelli; Adriana T Larregina; William J Shufesky; Mara L G Sullivan; Donna Beer Stolz; Glenn D Papworth; Alan F Zahorchak; Alison J Logar; Zhiliang Wang; Simon C Watkins; Louis D Falo; Angus W Thomson
Journal:  Blood       Date:  2004-07-29       Impact factor: 22.113

10.  Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL.

Authors:  Nagendra R Hegde; Claire Dunn; David M Lewinsohn; Michael A Jarvis; Jay A Nelson; David C Johnson
Journal:  J Exp Med       Date:  2005-10-10       Impact factor: 14.307

View more
  75 in total

1.  Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cells.

Authors:  Birgit Fogal; Tai Yi; Chen Wang; Deepak A Rao; Amir Lebastchi; Sanjay Kulkarni; George Tellides; Jordan S Pober
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

Review 2.  Microvesicles and viral infection.

Authors:  David G Meckes; Nancy Raab-Traub
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

Review 3.  Exosomes: immune properties and potential clinical implementations.

Authors:  Nathalie Chaput; Clotilde Théry
Journal:  Semin Immunopathol       Date:  2010-12-21       Impact factor: 9.623

4.  Human Cytomegalovirus Utilizes Extracellular Vesicles To Enhance Virus Spread.

Authors:  Nicholas T Streck; Yuanjun Zhao; Jeffrey M Sundstrom; Nicholas J Buchkovich
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

5.  Modification of the HCMV-specific IFN-γ release test (QuantiFERON-CMV) and a novel proposal for its application.

Authors:  Takahiro Kobayashi; Jun-Ichi Sato; Kazufumi Ikuta; Ryoko Kanno; Kyoko Nishiyama; Tetsuo Koshizuka; Ken Ishioka; Tatsuo Suzutani
Journal:  Fukushima J Med Sci       Date:  2017-06-22

Review 6.  Membrane vesicles as conveyors of immune responses.

Authors:  Clotilde Théry; Matias Ostrowski; Elodie Segura
Journal:  Nat Rev Immunol       Date:  2009-06-05       Impact factor: 53.106

Review 7.  Cell-cell communication via extracellular membrane vesicles and its role in the immune response.

Authors:  Inkyu Hwang
Journal:  Mol Cells       Date:  2013-06-25       Impact factor: 5.034

8.  Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin.

Authors:  James S Testa; Geraud S Apcher; Joseph D Comber; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

Review 9.  Regulation of immune responses by extracellular vesicles.

Authors:  Paul D Robbins; Adrian E Morelli
Journal:  Nat Rev Immunol       Date:  2014-03       Impact factor: 53.106

Review 10.  Extracellular vesicles in renal disease.

Authors:  Diana Karpman; Anne-Lie Ståhl; Ida Arvidsson
Journal:  Nat Rev Nephrol       Date:  2017-07-24       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.